Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

225 Articles

Jon C. Ogg | Apr 18, 2011 at 11:01 AM EDT

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

The drug sector has become rather boring and investors already know all about the ongoing patent expiration threats that loom…

Jon C. Ogg | Apr 14, 2011 at 11:38 AM EDT

Dividend Watch: Big Dividends in ADRs (AZN, GSK, NOK, TMX)

American Depository Receipts, or ADRs, are generally called American Depository Shares, or ADSs, now. We found after some routine screens…

Jon C. Ogg | Mar 2, 2011 at 8:17 AM EST

Top Analyst Upgrades & Downgrades (AZN, CNP, CEDC, FDO, GOOG, MAR, MGM, OPTR, CRM, SONS, UFPI, WFMI, XLNX, YHOO)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning.…

Jon C. Ogg | Feb 4, 2011 at 12:17 PM EST

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

The method of using capital from the corporate treasury to return capital to shareholders via share repurchase programs has long…

Jon C. Ogg | Dec 7, 2010 at 8:08 AM EST

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Jon C. Ogg | Sep 29, 2010 at 7:44 AM EDT

Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research notes: Applied Materials…

Jon C. Ogg | Sep 23, 2010 at 8:19 AM EDT

Top Analyst Upgrades and Downgrades (MO, AGU, AZN, ATHN, BRCD, DD, GSK, INAP, LO, MMYT, MOS, NBG, NVDA, POT)

There are many research calls this Thursday morning and these are just some of the top analyst upgrades, downgrades, and…

Jon C. Ogg | Jun 30, 2010 at 8:01 AM EDT

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research early this Wednesday. Some…

Jon C. Ogg | May 29, 2010 at 10:34 AM EDT

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

We have an unusual cast of characters in this week’s version of THE UNUSUAL SUSPECTS for the week ahead, with…

Douglas A. McIntyre | May 19, 2010 at 8:10 PM EDT

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past,…

Douglas A. McIntyre | Nov 17, 2009 at 11:37 AM EST

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once…

Douglas A. McIntyre | Aug 20, 2009 at 7:48 AM EDT

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

These are Thursday’s top ten analyst research summary upgrades, downgrades, and initiations from Wall Street brokerage firms: AstraZeneca (AZN) Cut…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Jul 30, 2009 at 3:28 PM EDT

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

You can just see the TV advertisements now… Wal-Mart and Uncle Sam are “rolling back” swine flu. The retailer is…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

1 … 12 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

Dividend Watch: Big Dividends in ADRs (AZN, GSK, NOK, TMX)

Top Analyst Upgrades & Downgrades (AZN, CNP, CEDC, FDO, GOOG, MAR, MGM, OPTR, CRM, SONS, UFPI, WFMI, XLNX, YHOO)

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

Top Analyst Upgrades and Downgrades (MO, AGU, AZN, ATHN, BRCD, DD, GSK, INAP, LO, MMYT, MOS, NBG, NVDA, POT)

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

The Next Blockbuster Drugs: A $170 Billion Opportunity

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

You Paid Into Social Security for 40 Years. The IRS Can Still Tax 85% of Your Check. These 3 ETFs Even the Score

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

AstraZeneca : AZN

All AstraZeneca Articles

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

Dividend Watch: Big Dividends in ADRs (AZN, GSK, NOK, TMX)

Top Analyst Upgrades & Downgrades (AZN, CNP, CEDC, FDO, GOOG, MAR, MGM, OPTR, CRM, SONS, UFPI, WFMI, XLNX, YHOO)

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

Top Analyst Upgrades and Downgrades (MO, AGU, AZN, ATHN, BRCD, DD, GSK, INAP, LO, MMYT, MOS, NBG, NVDA, POT)

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

The Next Blockbuster Drugs: A $170 Billion Opportunity

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

You Paid Into Social Security for 40 Years. The IRS Can Still Tax 85% of Your Check. These 3 ETFs Even the Score

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income